NASDAQ: PGEN

Advancing
Medicine with
PrecisionTM

Precigen is a dedicated discovery and clinical stage biopharmaceutical company advancing the next generation of gene and cell therapies using precision technology to target the most urgent and intractable diseases in our core therapeutic areas of immuno-oncology, autoimmune disorders, and infectious diseases.

Our technologies enable us to find innovative solutions for affordable biotherapeutics in a controlled manner. Precigen operates as an innovation engine progressing a preclinical and clinical pipeline of well-differentiated unique therapies toward clinical proof-of-concept and commercialization.

A NEW APPROACH
A NEW APPROACH

Next
Generation
Therapies

Our disciplined design approach uses non-viral and viral expression systems, genome, DNA, RNA and protein engineering, and a suite of precision bioengineering switch technologies controlling gene expression and regulation to deliver potent on-target gene and cellular multifunctional therapies with improved safety and efficacy.

IN THE BATTLE AGAINST CANCER
WHAT WE’RE FACING

Every minute counts

18 Lives Lost
Every Minute¹

1,000 Lives Lost
Every Hour¹

26,000+ Lives Lost
Each Day¹

800,000 Lives Lost
Each Month¹

We are driven by this urgency. Each minute is an opportunity to make a difference.

Careers

Join our team

Learn More

If you yearn for a career where you work with dedicated, smart people and what you do makes a meaningful impact on science, medicine, and patients, join our team. We are passionate about our people and seek to hire the best.

Learn More